Item 16. FORM 10-K SUMMARY

None.

-89-

PART IV	Signatures

RESMED INC. AND SUBSIDIARIES

SIG****NATURES

Under the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized persons below.

DATED August 12, 2020

ResMed Inc.

/s/ MICHAEL J. FARRELL
Michael J. Farrell
Chief executive officer
(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE

/S/ MICHAEL J. FARRELL	Chief executive officer and director	August 12, 2020
Michael J. Farrell	(Principal Executive Officer)

/S/ BRETT A. SANDERCOCK	Chief financial officer	August 12, 2020
Brett A. Sandercock	(Principal Financial Officer and Principal Accounting Officer)

/S/ PETER C. FARRELL	Non-executive chairman	August 12, 2020
Peter C. Farrell

/S/ CAROL J. BURT	Director	August 12, 2020
Carol J. Burt

/S/ JAN De WITTE	Director	August 12, 2020
Jan De Witte

/S/ RICHARD SULPIZIO	Director	August 12, 2020
Richard Sulpizio

/S/ RON TAYLOR	Director	August 12, 2020
Ron Taylor

/S/ KAREN DREXLER	Director	August 12, 2020
Karen Drexler

/S/ HARJIT GILL	Director	August 12, 2020
Harjit Gill

-90-

Previous: Item 15. EXHIBITS AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES

Item 16. FORM 10-K SUMMARY

Table of Contents